Related Experiment Videos
The Duett closure device: concept and experimental results
1John Muir Medical Center, Walnut Creek, California, USA. ggershony@vascularsolutions.com
Herz
|February 1, 2000
Summary
A new vascular sealing device, combining a balloon catheter and procoagulant, effectively achieves rapid hemostasis. This innovative device shows high success rates in sealing femoral arteries in dogs, even under anticoagulation.
Area of Science:
- Biomedical Engineering
- Vascular Surgery
- Hemostasis Research
Background:
- Percutaneous vascular procedures carry risks of bleeding.
- Effective hemostasis is crucial for patient safety and successful outcomes.
- Novel devices are needed to improve bleeding control, especially in anticoagulated patients.
Purpose of the Study:
- To evaluate the hemostatic efficacy of a novel vascular sealing device.
- The device combines a balloon catheter with a procoagulant agent.
- Assess performance in canine femoral arteries, including anticoagulated models.
Main Methods:
- Vascular sheaths were inserted into canine femoral arteries.
- The device was tested with a balloon catheter alone (n=6).
- The device with balloon catheter and procoagulant was tested (n=21).
- Hemostasis was assessed, including in anticoagulated animals compared to controls.
Main Results:
- The balloon catheter alone achieved immediate hemostasis in all 6 cases.
- The device with procoagulant achieved 95% hemostasis (20/21 attempts).
- In anticoagulated dogs, the device achieved hemostasis in 6.5 +/- 3.4 minutes versus controls (p < 0.001).
Conclusions:
- The novel vascular sealing device demonstrates significant hemostatic capabilities.
- It provides rapid and effective bleeding control following percutaneous vascular interventions.
- The device shows promise for use in both normal and anticoagulated patients.